Cost of medicines in hospitals increased by 11% in 2017/2018 The cost of medicines prescribed in hospitals has increased by nearly 11% over the past year, according to official NHS data.…
UK developer of medical cannabis products raises $345m through share sale The UK biopharmaceutical company GW Pharmaceuticals, a leading global developer of medicinal cannabis products, has released 2.1 million shares on the US stock exchange raising US$345m.…
Health literacy, medication adherence and thriving healthcare systems: connecting the dots Medication adherence is not only the mantra of modern medicine, but also the catalyst to achieve prevention, cure, and wellbeing.…
LSE researchers propose more holistic method for evaluating new medicines A new methodology to help decision-makers and stakeholders evaluate new medicines has been developed by London School of Economics researchers.…
New Medicines Service could save NHS £517.6m, economic evaluation finds The New Medicines Service has the potential to save the NHS hundreds of millions of pounds and could be expanded to cover more long-term conditions, according to UK researchers.…
What pharmacist Annie Pannelay does as a consultant for a media company Annie Pannelay works in the healthcare practice of the Economist Intelligence Unit — as a pharmacist, not a journalist.…
Daily Vaseline use could be cost-effective way to prevent eczema Recent attention has turned to ways to prevent atopic dermatitis, which is associated with significant expenditure as well as comorbidities, from developing in children.…
NICE recommends osimertinib for inclusion in revamped cancer drugs fund Osimertinib has become the first new drug to be recommended for inclusion in the revamped cancer drugs fund by the National Institute for Health and Care Excellence.…
Drug switching could save US health system billions Drug classes with the highest excess expenditure in the United States are statins, atypical antipsychotics and proton pump inhibitors, study finds.…
Global HPV vaccination provides greatest economic benefit to high income countries Manufacturers have received economic returns worth five times their original investment in HPV vaccine development, say researchers…
